Antimicrobial catheters in the ICU: is the juice worth the squeeze?
Catheter-related bloodstream infection is one of the most serious complications of central venous access devices. Antimicrobial-coated catheters represent one novel strategy to prevent catheter-related bloodstream infection. A comprehensive economic evaluation is essential to guide informed decision-making regarding the adoption of this technology and its expected benefits in healthcare institutions.
Safdar
Nasia
N
Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, H4/572, Madison, WI 53792, USA. ns2@medicine.wisc.edu
D000891:Anti-Infective Agents, Local / Q000191:economics / Q000627:therapeutic use*; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000295:instrumentation*; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000517:prevention & control*; D006801:Humans; D018805:Sepsis / Q000517:prevention & control*
D000891:Anti-Infective Agents, Local